SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-15-001840
Filing Date
2015-03-19
Accepted
2015-03-19 16:53:30
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K abio-10k_20141231.htm 10-K 2512597
2 EX-10.64 abio-ex1064_20141231390.htm EX-10.64 136225
3 EX-23.1 abio-ex231_201412318.htm EX-23.1 3619
4 EX-31.1 abio-ex311_201412316.htm EX-31.1 12300
5 EX-31.2 abio-ex312_201412317.htm EX-31.2 13265
6 EX-32.1 abio-ex321_201412319.htm EX-32.1 8613
  Complete submission text file 0001564590-15-001840.txt   9154410

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abio-20141231.xml EX-101.INS 1219825
8 XBRL TAXONOMY EXTENSION SCHEMA abio-20141231.xsd EX-101.SCH 43108
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20141231_cal.xml EX-101.CAL 40639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20141231_def.xml EX-101.DEF 172538
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20141231_lab.xml EX-101.LAB 420069
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20141231_pre.xml EX-101.PRE 297296
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22873 | Film No.: 15713393
SIC: 2835 In Vitro & In Vivo Diagnostic Substances